• Explore /
  • Poster
  • / Antitumor activity of dostarlimab in patients with mismatch repair-deficient/microsatellite instability–high tumors: A combined analysis of two cohorts in the GARNET study.

Antitumor activity of dostarlimab in patients with mismatch repair-deficient/microsatellite instability–high tumors: A combined analysis of two cohorts in the GARNET study.

Abstract Video & Slides Poster

Authors

null

Dominique Berton

GINECO & Institut de Cancerologie de l'Ouest, Centre René Gauducheau, Saint-Herblain, France

Dominique Berton , Susana N. Banerjee , Giuseppe Curigliano , Sara Cresta , Hendrik-Tobias Arkenau , Cyril Abdeddaim , Rebecca Sophie Kristeleit , Andrés Redondo , Charles A. Leath III, Antonio Antón Torres , Wei Guo , Ellie Im , Thierry Andre

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Immunotherapy

Track

Developmental Therapeutics—Immunotherapy

Sub Track

PD1/PD-L1 Inhibitor Monotherapy

Clinical Trial Registration Number

NCT02715284

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 2564)

DOI

10.1200/JCO.2021.39.15_suppl.2564

Abstract #

2564

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

Poster

2020 Gastrointestinal Cancers Symposium

Safety and efficacy of anti-PD-1 antibody dostarlimab in patients (pts) with mismatch repair deficient (dMMR) GI cancers.

Safety and efficacy of anti-PD-1 antibody dostarlimab in patients (pts) with mismatch repair deficient (dMMR) GI cancers.

First Author: Thierry Andre

First Author: Thierry Andre

First Author: Thierry Andre

First Author: Jennifer Hanlon